Medtronic (MDT)

Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.

WASHINGTON D.C. — In a series of high-stakes maneuvers that have redefined the role of the U.S. Treasury, Secretary Scott Bessent has signaled a fundamental shift in American economic policy. As of March 16, 2026, the architect of the administration’s "Parallel Prosperity" agenda is simultaneously navigating a volatile

As of March 16, 2026, the medical technology landscape is grappling with a stark reminder of the vulnerabilities inherent in the digital shift of healthcare. Stryker Corporation (NYSE: SYK), a global titan in medical devices and equipment, finds itself at the center of a developing storm following a massive cyberattack that has sent ripples through [...]

HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.

Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends to retire. The decline, which wiped out significant market capitalization in a single session, reflects investor anxiety over the

On a day marked by deepening global uncertainty and a sharp spike in energy costs, the healthcare sector emerged as the primary beneficiary of a massive "risk-off" migration by institutional investors. As of the market close on March 10, 2026, the Healthcare Select Sector SPDR Fund (NYSEARCA:XLV) gained 1%

They are down, but they are not out.

Medtronic announces a $550 million Scientia Vascular acquisition to strengthen its neurovascular portfolio.

As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry bellwethers, once buoyed by post-pandemic expansion and aggressive R&D spending, are now issuing sober forecast revisions that reflect a

Edwards Lifesciences has outperformed the S&P 500 recently, and analysts remain moderately optimistic about the stock’s prospects.

This Dividend King is out of favor, and this medical device peer has just introduced an exciting new product.

These stocks can be slow-and-steady wealth compounders.

MiniMed, a spinoff of Medtronic, is expected to price its IPO on March 5.

Intuitive Surgical is the example to keep in mind as you watch this sleeper stock and its new surgical robot.

The established medical device titan is expanding into a promising new direction -- robotic surgery.

The best long-term winners often start small.

One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this competitor.

Medtronic has underperformed the S&P 500 over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered safety but lacked the high-octane growth of its specialized med-tech peers. That narrative is shifting rapidly. Today, February 24, 2026, marks a watershed moment for [...]

In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third fiscal quarter of 2026. On February 17, 2026, the Dublin-based medical device giant announced total revenue of $9.017 billion,

The stock is especially attractive to income seekers.

The company operates in a field where spending often isn't optional.

The only healthcare stock I own is Medtronic, and I'm not planning to sell it anytime soon.